MedPath

EverFlex™ Self-expanding Peripheral Stent With Entrust™ Delivery System Clinical Study

Not Applicable
Completed
Conditions
Peripheral Arterial Diseases
Interventions
Device: EverFlex™ stent with Entrust™ delivery system
Registration Number
NCT02066740
Lead Sponsor
Medtronic Endovascular
Brief Summary

The purpose of this study is to collect acute confirmatory data to evaluate technical success and acute safety of the EverFlex™ self-expanding peripheral stent with Entrust™ delivery system.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
34
Inclusion Criteria
  • Has stenotic, restenotic (from PTA or adjunct therapy, not including stents or stent grafts),
  • or occluded lesion(s) located in the superficial femoral artery (SFA) and/or proximal popliteal artery (PPA) suitable for primary stenting.
Exclusion Criteria
  • Has undergone previous implantation of stent(s) or stent graft(s) in the target vessel.

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
EverFlex™ stent with Entrust™ delivery systemEverFlex™ stent with Entrust™ delivery system-
Primary Outcome Measures
NameTimeMethod
Absence of Stent ElongationIntra operative

Absence of stent elongation is achieved when the implanted stent length does not exceed the allowed stent length

Successful Stent DeploymentProcedure

Successful stent deployment to be assessed based on stent delivery, lesion coverage and accuracy of deployment.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Klinikum Weiden

🇩🇪

Weiden, Germany

© Copyright 2025. All Rights Reserved by MedPath